Initial tumor markers revealed the following: total PSA 392 ng/mL (ref: <4), free PSA 49.7 ng/mL, and free prostate-specific antigen / total prostate-specific antigen (fPSA/tPSA) ratio of 0.13. This evidence concerns the gene KLK3 and neoplasm.